4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club

Plenary Session

0:00

-19:52

4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club

I perform an analysis of the AGILE trial that cam…

Vinay Prasad MD MPH

Apr 21, 2022

I perform an analysis of the AGILE trial that came out in NEJM today; I find 6 huge problems. Follow PS on twitter; and write to us to let us know what you think

Discussion about this episode

Ready for more?

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

Vinay Prasad’s Observations and Thoughts

4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club

Discussion about this episode

Ready for more?